Brown. Hematology: Principles and Procedures. Third Edition, 1980, pp. 127-128.* |
Rand et al. Blood Clotting in Minimally Altered Whole Blood. Blood, vol. 88, No. 9, 1996, pp. 3432-3445.* |
Ewald et al. Plasma-Mediated Activation of Contact System in Repsonse to Pharmacological Thrombolysis. Circulation, vol. 91, No. 1, 1995, pp. 28-36.* |
Doellgast, G.J. et al., Clin. Chem. 34/2:294-299 (1988). |
Cornelis van't Veer et al., J. Biol. Chem. 14/7:4367-4377 (1997). |
Cawthern, K. M., et al. “Regulation of Thrombin Generation By Tissue Factor, Factor VIIIs And Factor XIa In a Whole Blood Model”, Blood 88:520a, Abstract 2067 (1996). |
Rand, M.D. et al., Blood 88/9:3432-3445 (1996). |
K. G. Mann, et al., “Surface-Dependent Reactions of the Vitamin K-Dependent Enzyme Compleses”, Blood, vol. 76, No. 1, (1990), pp. 1-16. |
M. Munakata, et al. “Evaluation of the Factor XIIa Assay Kit”, Rinsho Byori, vol. 44, No. 9, (1996), pp. 883-888. |
D. J. Moliterno, MD, et al. “Effect of Platelet Glycoprotein IIb/IIIa Integrin Blockade on Activated Clotting Time During Percutaneous Transluminal Coronary Angioplastyy or Directional Atherectomuy (The EPIC Trial)”, The American Journal of Cardiology, vol. 75 (1995), pp. 559-562. |
E. W. Davie, et al. “The Coagulation Cascade:Initiation, Maintenance, and Regulation”, Biochemistry, vol. 30, No. 43 (1991), pp. 10363-10370. |
D. J. Schneider, (MD), et al. “Differential Effects of Anticoagulants on the Activation pf Platelets Ex Vivo”, Circulation, vol. 96, No. 9, (1997), pp. 2877-2883. |
T. Ammar, MD, et al. “In Vitro Effects of the Platelet Glycoprotein IIb/IIIa Receptor Antagonist c7E3 Fab on the Activated Clotting Time”, Circulation. vol. 95, No. 3, (1997), pp. 614-617. |
B. Osterud, et al. “Activation of Factor IX By The Reaction Product of Tissue Factor and Factor VII: Additional Pathway For Initiating Blood Coagulation”, Proc. Natl. Acad. Sci. (USA), vol. 74, No. 12 (1977), pp. 5260-5264. |
O. D. Ratnoff, et al. “Inhibition of Ellagic Acid-Activated Hageman Factor (Factor XII) and Hageman Factor Fragments by Popcorn Inhibitor”, Proc. Soc. Exp. Biol. Med., vol. 166, No. 2, (1981), pp. 297-299. |
S. A. Kambhu, et al. “Inhibition of Hageman Factor (Factor XII) By Popcorn Inhibitor”, J. Lab. Clin. Med. (USA), vol. 105, No. 5, (1985), pp. 625-628. |
J. H. Lawson, et al. “A Model For The Tissue Factor Pathway To Thrombin”, J. Biol. Chemistry, vol. 269, No. 37 (1994), pp. 23357-23366. |
L. C. Pedersen, et al. “The Corn Inhibitor of Blood Coagulation Factor XIIa Crystallization and Preliminary Crystallographic Analysis”, J. Mol. Biol. (England), vol. 236, No. 1, (1994), pp. 385-387. |
S. I. Rapaport, et al. “The Tissue Factor Pathway: How It Has Become a ‘Prima Ballerina’” Thrombosis and Haemostasis, vol. 74, No. 1, (1995), pp. 7-17. |
Y. Hojima, et al. “Hageman Factor Fragment Inhibitor In Corn Seeds: Purification and Characterization”, Thrombosis Research, vol. 20, No. 2, (1980), pp. 149-162. |
Gregory A. Ewald M.D., et al.; “Plasmin-Mediated Activation of Contact System in Response to Pharmacological Thrombolysis”, Circulation, vol. 91, No. 1, 1995, pp. 28-36. |
Notification of Transmittal of the International Search Report or the Declaration (PCT/US99/12631). |